246 results on '"Pisters, Peter W.T."'
Search Results
2. Serum carbohydrate antigen 19-9 represents a marker of response to neoadjuvant therapy in patients with borderline resectable pancreatic cancer
3. Predicting the risks of venous thromboembolism versus post-pancreatectomy haemorrhage: analysis of 13 771 NSQIP patients
4. Radiographic Tumor–Vein Interface as a Predictor of Intraoperative, Pathologic, and Oncologic Outcomes in Resectable and Borderline Resectable Pancreatic Cancer
5. Treatment Sequencing for Resectable Pancreatic Cancer: Influence of Early Metastases and Surgical Complications on Multimodality Therapy Completion and Survival
6. Morbidity and Mortality after Pancreaticoduodenectomy in Patients with Borderline Resectable Type C Clinical Classification
7. Soft Tissue Sarcoma
8. A High Positive Lymph Node Ratio is Associated with Distant Recurrence after Surgical Resection of Ampullary Carcinoma
9. Selective Reoperation for Locally Recurrent or Metastatic Pancreatic Ductal Adenocarcinoma Following Primary Pancreatic Resection
10. Risk of venous thromboembolism outweighs post-hepatectomy bleeding complications: analysis of 5651 National Surgical Quality Improvement Program patients
11. Microscopically Positive Margins for Primary Gastrointestinal Stromal Tumors: Analysis of Risk Factors and Tumor Recurrence
12. Yield of clinical and radiographic surveillance in patients with resected pancreatic adenocarcinoma following multimodal therapy
13. Effect of Neoadjuvant Chemoradiation and Surgical Technique on Recurrence of Localized Pancreatic Cancer
14. 2 - Evaluación clínica y tratamiento de los tumores de partes blandas
15. Borderline Resectable Pancreatic Cancer: The Importance of This Emerging Stage of Disease
16. Diagnosis and Management of Soft Tissue Sarcomas
17. Improving Goal Concordant Care Among 10 Leading Academic U.S. Cancer Hospitals: A Collaboration of the Alliance of Dedicated Cancer Centers
18. Delayed Recovery after Pancreaticoduodenectomy: A Major Factor Impairing the Delivery of Adjuvant Therapy?
19. Future Chemoradiation Strategies in Pancreatic Cancer
20. The learning curve in pancreatic surgery
21. 2 - Clinical Evaluation and Treatment of Soft Tissue Tumors
22. The argument for pre-operative chemoradiation for localized, radiographically resectable pancreatic cancer
23. Venous resection in pancreatic cancer surgery
24. Operative trials: the opportunity beckons—an update on the American College of Surgeons Oncology Group
25. Current Approaches and Future Strategies for Pancreatic Carcinoma
26. Contributors
27. Sarcomas of Soft Tissue
28. Adjuvant imatinib therapy for gastrointestinal stromal tumors
29. Gastrointestinal Stromal Tumors: Current Management
30. Pancreaticoduodenectomy After Placement of Endobiliary Metal Stents
31. Carcinoid tumors of the duodenum
32. Long-segment, supercharged, pedicled jejunal flap for total esophageal reconstruction
33. Clinical outcomes of molecularly confirmed clear cell sarcoma from a single institution and in comparison with data from the surveillance, epidemiology, and end results registry
34. Lymphadenectomy for Isolated Lymph Node Metastasis From Extremity Soft-Tissue Sarcomas
35. The impact of ethnicity on the presentation and prognosis of patients with gastric adenocarcinoma: results from the National Cancer Data Base
36. Periosteal Margin in Soft-Tissue Sarcoma
37. Complications of combined modality treatment of primary lower extremity soft-tissue sarcomas
38. Phase II Trial of Preoperative Chemoradiation in Patients With Localized Gastric Adenocarcinoma (RTOG 9904): Quality of Combined Modality Therapy and Pathologic Response
39. Retroperitoneal Sarcomas: Combined-Modality Treatment Approaches
40. Phase I Trial Evaluating the Safety of Bevacizumab With Concurrent Radiotherapy and Capecitabine in Locally Advanced Pancreatic Cancer
41. Preoperative Chemotherapy and Split-Course Radiation Therapy for Patients With Localized Soft Tissue Sarcomas: Home Run, Base Hit, or Strike Out?
42. Clinicopathologic Behavior of Gastric Adenocarcinoma in Hispanic Patients: Analysis of a Single Institutionʼs Experience Over 15 Years
43. Retroperitoneal sarcoma: a population-based analysis of epidemiology, surgery, and radiotherapy
44. ACCO: ASCO Core Curriculum Outline
45. Pancreaticoduodenectomy with vascular resection: margin status and survival duration
46. Neoadjuvant therapy for resectable pancreatic cancer
47. Staging and preoperative evaluation of upper gastrointestinal malignancies
48. Cost-effectiveness of pulmonary resection and systemic chemotherapy in the management of metastatic soft tissue sarcoma: a combined analysis from the University of Texas M. D. Anderson and Memorial Sloan-Kettering Cancer Centers
49. Cohort Analysis of Patients With Localized, High-Risk, Extremity Soft Tissue Sarcoma Treated at Two Cancer Centers: Chemotherapy-Associated Outcomes
50. Phase I Trial of Preoperative Doxorubicin-Based Concurrent Chemoradiation and Surgical Resection for Localized Extremity and Body Wall Soft Tissue Sarcomas
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.